AWHP highlights the critical role that nonprescription, over-the-counter drugs play in supporting the health of Americans nationwide in comments to a recent FDA RFI and a new white paper.

AWHP is proud to present its 2025 End of Year Report sharing highlights from this year’s efforts.

In collaboration with a diverse coalition of public health leaders and advocacy organizations, AWHP developed a consensus statement aimed at transforming the way osteoporosis is perceived, identified, and managed in the U.S.

Learn from experts on why vaccines are the safest and most effective tool we have to prevent infectious diseases as children head back to school.

Read highlights from AWHP’s conversation with Dr. Louisa Ziglar on access to osteoporosis prevention, screening, and care.

Learn about how AWHP’s survey results underscore the importance of Medicaid for women.

AWHP CEO Millicent Gorham reflects on key learnings from AWHP’s second annual Leadership Meeting.

To mark Minority Health Month, AWHP partnered with the American Nurses Association and the American Kidney Fund to bring women leaders together for a powerful conversation on health policy and identified three urgent policy priorities designed to put women of color at the forefront of preventive health.

In December 2024, the U.S. Preventive Services Task Force (USPSTF) issued new draft guidelines for cervical cancer screening. AWHP submitted a letter during the public comment period for consideration as the USPSTF finalizes the guidelines.